Vineet Laboratories (BOM:543298) Change In Receivables : ₹0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Vineet Laboratories Change In Receivables?

Vineet Laboratories's change in receivables for the quarter that ended in Dec. 2023 was ₹0 Mil. It means Vineet Laboratories's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Vineet Laboratories's change in receivables for the fiscal year that ended in Mar. 2023 was ₹51 Mil. It means Vineet Laboratories's Accounts Receivable declined by ₹51 Mil from Mar. 2022 to Mar. 2023 .

Vineet Laboratories's Accounts Receivable for the quarter that ended in Dec. 2023 was ₹0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Vineet Laboratories's Days Sales Outstanding for the three months ended in Dec. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Vineet Laboratories's liquidation value for the three months ended in Dec. 2023 was ₹0 Mil.

Vineet Laboratories Change In Receivables Historical Data

The historical data trend for Vineet Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vineet Laboratories Change In Receivables Chart

Vineet Laboratories Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Receivables

Get a 7-Day Free Trial

-427.14

65.16

50.70

Vineet Laboratories Quarterly Data
	Mar17	Mar18	Mar19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial											-	-	-	-	-

Vineet Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Vineet Laboratories (BOM:543298) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Vineet Laboratories's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	326.47	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Vineet Laboratories's accounts receivable are only considered to be worth 75% of book value:

Vineet Laboratories's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	0	+	0.75 * 0	+	0.5 * 0
=	0

Vineet Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Vineet Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Vineet Laboratories (BOM:543298) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vineet Laboratories Ltd (BOM:543298) » Definitions » Change In Receivables

Traded in Other Exchanges

VINEETLAB:India

Address

5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre, Chintalakunta, L.B.Nagar, Hyderabad, TG, IND, 500 074

Website

https://www.vineetlabs.co.in

Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.

Vineet Laboratories (BOM:543298) Headlines

No Headlines